Peninsula Pharmaceuticals

Focused on development and commercialization of antibiotics

Human health & social work | Northern America | Health Improvement |

 

• 
• http://www.peninsulapharm.com

Overview

Peninsula was acquired by Johnson & Johnson on June 30th 2005. Peninsula is a biopharmaceutical company focused on the development and commercialization of antibiotics to treat life threatening infections. The Company s mission is to develop optimal anti infective therapies that offer improved efficacy dosing and safety characteristics over existing therapies. In addition to DBL Investors investors include Canaan Partners and Domain Associates.

Industry	Legal Structure	Operating Status	Employees
Human health & social work		Out of Business

Funding and Financing Rounds

Team

Impact

Social Objectives:

Environmental Objectives:

Operational Impact:

Impact Reports & Metrics

Offices